精品国产精品免费在线观看|亚洲一级高清在线观看|亚洲乱码尤物193yw|亚洲综合狠狠99婷婷

      Therapeutic Advances In Infectious Disease
      • 數(shù)據(jù)庫收錄SCIE
      • 年發(fā)文量71

      Therapeutic Advances In Infectious Disease

      期刊中文名:傳染病治療進展ISSN:2049-9361E-ISSN:2049-937X

      該雜志國際簡稱:THER ADV INFECT DIS,是由出版商SAGE Publishing出版的一本致力于發(fā)布--研究新成果的的專業(yè)學術期刊。主要發(fā)表刊登有創(chuàng)見的學術論文文章、行業(yè)最新科研成果,扼要報道階段性研究成果和重要研究工作的最新進展,選載對學科發(fā)展起指導作用的綜述與專論,促進學術發(fā)展,為廣大讀者服務。該刊是一本國際優(yōu)秀雜志,在國際上有很高的學術影響力。

      基本信息:
      期刊簡稱:THER ADV INFECT DIS
      是否OA:開放
      是否預警:
      Gold OA文章占比:93.27%
      出版信息:
      出版地區(qū):United States
      出版語言:English
      出版商:SAGE Publishing
      評價信息:
      JCR分區(qū):Q2
      影響因子:3.8
      CiteScore:5.3
      雜志介紹 JCR分區(qū) CiteScore 投稿經驗

      雜志介紹

      Therapeutic Advances In Infectious Disease雜志介紹

      《Therapeutic Advances In Infectious Disease》是一本以English為主的開放獲取國際優(yōu)秀期刊,中文名稱傳染病治療進展,本刊主要出版、報道領域的研究動態(tài)以及在該領域取得的各方面的經驗和科研成果,介紹該領域有關本專業(yè)的最新進展,探討行業(yè)發(fā)展的思路和方法,以促進學術信息交流,提高行業(yè)發(fā)展。該刊已被國際權威數(shù)據(jù)庫SCIE收錄,為該領域相關學科的發(fā)展起到了良好的推動作用,也得到了本專業(yè)人員的廣泛認可。該刊最新影響因子為3.8,最新CiteScore 指數(shù)為5.3。

      本刊近期中國學者發(fā)表的論文主要有:

      • Assessment and associated factors of comprehensive HIV knowledge in an at-risk population: a cross-sectional study from 19,286 young persons in Nigeria

        Author: Kareem, Yusuf Olushola; Dorgbetor, Cyprian Issahaku; Ameyaw, Edward Kwabena; Abubakar, Zubaida; Adelekan, Babatunde; Goldson, Erika; Mueller, Ulla; Adegboye, Oyelola

      英文介紹

      Therapeutic Advances In Infectious Disease雜志英文介紹

      Therapeutic Advances in Infectious Disease is an international academic journal dedicated to the treatment of infectious diseases. This magazine is dedicated to providing a platform for infectious disease researchers, clinical doctors, and related professionals worldwide to exchange the latest research findings, clinical practices, and treatment strategies. By publishing high-quality academic papers, this journal aims to promote knowledge innovation and clinical practice improvement in the field of infectious disease treatment.

      The journal has a wide range of content, covering multiple aspects from basic research to clinical applications, including but not limited to research on the treatment of bacterial, viral, fungal, and parasitic infectious diseases. The types of articles include original research papers, review articles, case reports, clinical trial results, and expert opinions, which reflect the cutting-edge dynamics and challenges in the field of infectious disease treatment. The magazine pays special attention to treatment strategies for emerging infectious diseases, solutions to antibiotic resistance issues, the latest developments in vaccine development, and analysis of global infectious disease trends. In addition, the magazine also focuses on ethical, legal, and social issues in the treatment of infectious diseases, emphasizing the need to consider their impact on society and the environment while providing effective treatment.

      JCR分區(qū)(2023-2024年最新版)

      Therapeutic Advances In Infectious Disease雜志 JCR分區(qū)信息

      按JIF指標學科分區(qū)
      學科:INFECTIOUS DISEASES
      收錄子集:ESCI
      分區(qū):Q2
      排名:34 / 132
      百分位:

      74.6%

      按JCI指標學科分區(qū)
      學科:INFECTIOUS DISEASES
      收錄子集:ESCI
      分區(qū):Q3
      排名:75 / 132
      百分位:

      43.56%

      JCR分區(qū):JCR分區(qū)來自科睿唯安公司,JCR是一個獨特的多學科期刊評價工具,為唯一提供基于引文數(shù)據(jù)的統(tǒng)計信息的期刊評價資源。每年發(fā)布的JCR分區(qū),設置了254個具體學科。JCR分區(qū)根據(jù)每個學科分類按照期刊當年的影響因子高低將期刊平均分為4個區(qū),分別為Q1、Q2、Q3和Q4,各占25%。JCR分區(qū)中期刊的數(shù)量是均勻分為四個部分的。

      CiteScore 評價數(shù)據(jù)(2024年最新版)

      Therapeutic Advances In Infectious Disease雜志CiteScore 評價數(shù)據(jù)

      • CiteScore 值:5.3
      • SJR:1.015
      • SNIP:0.983
      學科類別 分區(qū) 排名 百分位
      大類:Medicine 小類:Pharmacology (medical) Q2 94 / 272

      65%

      大類:Medicine 小類:Infectious Diseases Q2 134 / 344

      61%

      歷年影響因子和期刊自引率

      投稿經驗

      Therapeutic Advances In Infectious Disease雜志投稿經驗

      該雜志是一本國際優(yōu)秀雜志,在國際上有較高的學術影響力,行業(yè)關注度很高,已被國際權威數(shù)據(jù)庫SCIE收錄,該雜志在綜合專業(yè)領域專業(yè)度認可很高,對稿件內容的創(chuàng)新性和學術性要求很高,作為一本國際優(yōu)秀雜志,一般投稿過審時間都較長,投稿過審時間平均 9 Weeks ,如果想投稿該刊要做好時間安排。版面費不祥。該雜志近兩年未被列入預警名單,建議您投稿。如您想了解更多投稿政策及投稿方案,請咨詢客服。

      免責聲明

      若用戶需要出版服務,請聯(lián)系出版商。